Cost-Effectiveness of Pazopanib as First Line Treatment for Metastatic Renal Cell Carcinoma in Brazil- Updated Analysis
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.2030
https://www.valueinhealthjournal.com/article/S1098-3015(13)03942-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1858
First Page :
A685
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03942-9&doi=10.1016/j.jval.2013.08.2030